{
    "info": {
        "nct_id": "NCT03949283",
        "official_title": "Standard Chemotherapy Versus Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer",
        "inclusion_criteria": "1. Informed consent obtained and signed.\n2. Participant is willing and able to commit to study procedures including long-term follow-up visit(s);\n3. Participant must be a female and at least 18 years of age at the time of enrollment.\n4. Negative pregnancy test for women of childbearing potential.\n5. Participant has been diagnosed with recurrent platinum resistant epithelial ovarian, peritoneal, or fallopian tube carcinoma.\n6. Participants must have an evaluable disease - defined as one of the following:\n\n1) RECIST 1.1 measurable disease (defined as one or more solid and/or cystic tumors on cross-sectional imaging that measures 1 cm or greater in long axis and/or lymph nodes measuring 1.5 cm or greater in short axis) 2) Evaluable disease (defined as solid and/or cystic tumors on radiographic imaging or physical exam that do not meet RECIST 1.1 definitions for target lesions) with elevated CA125 (GCIG recurrence and response criteria) by more than 2 times the upper limits of normal, confirmed in two successive samples, drawn at least one week apart).\n\n7. Participant has agreed to provide a core biopsy of the primary site, a secondary metastatic site, or to undergo a paracentesis or thoracentesis for fluid collection.\n\n8. An adequate fresh sample can be provided and submitted for ChemoID testing.\n\n9. Participant has disease of one of the following histologic epithelial cell types: high-grade serous adenocarcinoma, endometrioid adenocarcinoma, undifferentiated carcinoma, transitional cell carcinoma, clear cell carcinoma, or adenocarcinoma, not otherwise specified (N.O.S.). Cytologic confirmation of diagnosis is acceptable for participants treated with neoadjuvant therapy who have not had a surgical procedure for a histologic confirmation. Patients with low-grade serous or mucinous adenocarcinoma are not eligible, nor are patients with pure ovarian sarcomas.\n\n10. Participant has received ≤ 5 prior regimens including at least one platinum-based regimen for their ovarian, peritoneal, or fallopian tube carcinoma.\n\n11. Participant must have an estimated life expectancy of greater than six months, as determined by the investigator.\n\n12. Participant requires chemotherapy and the investigator plans to administer one of the regimens of interest as deemed by her physician.\n\n13. Participant must have an ECOG Performance Status Score of ≤ 2, KPS≥70, or 0-2 GOG status.\n\n14. Adequate laboratory values within 60 days of enrollment to study defined as follows:\n\n1. ANC ≥ 1500/mm3\n2. Hgb ≥ 10 mg/dl\n3. Hct ≥ 28%\n4. Platelet count ≥ 100,000/μL\n5. Serum creatinine ≤ 2.0 mg/dl\n6. Total bilirubin ≤ 2.5 mg/dl\n7. AST/SGOT ≤ 3 times ULN. If intrahepatic liver metastases are present, AST and ALT must be ≤ 5 times institutional ULN.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
        "exclusion_criteria": "1. Use of Avastin planned to treat participant.\n2. Participant has ovarian stromal, germ cell tumors or pure sarcomas.\n3. Participant has borderline carcinoma (uncertain malignant potential), mutinous or low-grade serous carcinoma.\n4. Participant is pregnant or lactating.\n5. Participants of childbearing potential not employing adequate contraception.\n6. Participants who are at risk of failure of compliance to the visit schedules and procedures including those with psychiatric disease that would substantially impact compliance or consent.\n7. Estimated life expectancy of <6 months, as estimated by the investigator in consultation with participating oncologists.\n8. Participants with symptomatic cardiac conditions (i.e. NYHA class III/IV or uncompensated angina).\n9. Enrollment in another clinical study that precludes allowing the oncologist to select chemotherapy regimens.\n10. Previously participated in this study.\n11. Any condition that would, in the opinion of the investigator, place the participant at an unacceptable risk, or render the participant unable to meet the requirements of the protocol (including long-term study follow-up).\n12. CA-125 only disease without RECIST 1.1 measurable or otherwise evaluable disease.\n13. Patients with third space fluid (for example pleural effusions) as only site of disease.\n14. Participant may not use any complementary or alternative medicines including natural herbal products or folk remedies as they may interfere with the effectiveness of the study treatments.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "identified_line": {
                "line": "Must have minimum age of 18 Years",
                "criterions": [
                    {
                        "exact_snippets": "minimum age of 18 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "minimum age of 18 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "11. Participant must have an estimated life expectancy of greater than six months, as determined by the investigator.",
                "criterions": [
                    {
                        "exact_snippets": "estimated life expectancy of greater than six months",
                        "criterion": "life expectancy",
                        "requirement": {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "estimated life expectancy of greater than six months",
                        "criterion": "life expectancy",
                        "requirement": {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "4. Negative pregnancy test for women of childbearing potential.",
                "criterions": [
                    {
                        "exact_snippets": "Negative pregnancy test for women of childbearing potential",
                        "criterion": "pregnancy test",
                        "requirement": {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        }
                    },
                    {
                        "exact_snippets": "for women of childbearing potential",
                        "criterion": "sex and reproductive status",
                        "requirement": {
                            "requirement_type": "applicability",
                            "expected_value": "women of childbearing potential"
                        }
                    }
                ]
            },
            "logical_structure": {
                "condition": {
                    "exact_snippets": "for women of childbearing potential",
                    "criterion": "sex and reproductive status",
                    "requirement": {
                        "requirement_type": "applicability",
                        "expected_value": "women of childbearing potential"
                    }
                },
                "then_criteria": {
                    "exact_snippets": "Negative pregnancy test for women of childbearing potential",
                    "criterion": "pregnancy test",
                    "requirement": {
                        "requirement_type": "result",
                        "expected_value": "negative"
                    }
                },
                "else_criteria": null
            }
        },
        {
            "identified_line": {
                "line": "12. Participant requires chemotherapy and the investigator plans to administer one of the regimens of interest as deemed by her physician.",
                "criterions": [
                    {
                        "exact_snippets": "Participant requires chemotherapy",
                        "criterion": "chemotherapy",
                        "requirement": {
                            "requirement_type": "requirement",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "the investigator plans to administer one of the regimens of interest as deemed by her physician",
                        "criterion": "planned regimen of interest",
                        "requirement": {
                            "requirement_type": "planned_administration",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Participant requires chemotherapy",
                        "criterion": "chemotherapy",
                        "requirement": {
                            "requirement_type": "requirement",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "the investigator plans to administer one of the regimens of interest as deemed by her physician",
                        "criterion": "planned regimen of interest",
                        "requirement": {
                            "requirement_type": "planned_administration",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "1. ANC ≥ 1500/mm3",
                "criterions": [
                    {
                        "exact_snippets": "ANC ≥ 1500/mm3",
                        "criterion": "absolute neutrophil count (ANC)",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1500,
                                "unit": "mm3"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "ANC ≥ 1500/mm3",
                        "criterion": "absolute neutrophil count (ANC)",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1500,
                                "unit": "mm3"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "2. Participant is willing and able to commit to study procedures including long-term follow-up visit(s);",
                "criterions": [
                    {
                        "exact_snippets": "Participant is willing and able to commit to study procedures including long-term follow-up visit(s)",
                        "criterion": "commitment to study procedures",
                        "requirement": {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Participant is willing and able to commit to study procedures including long-term follow-up visit(s)",
                        "criterion": "commitment to study procedures",
                        "requirement": {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Participant is willing and able to commit to study procedures including long-term follow-up visit(s)",
                        "criterion": "commitment to study procedures",
                        "requirement": {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Participant is willing and able to commit to study procedures including long-term follow-up visit(s)",
                        "criterion": "commitment to study procedures",
                        "requirement": {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "6. Total bilirubin ≤ 2.5 mg/dl",
                "criterions": [
                    {
                        "exact_snippets": "Total bilirubin ≤ 2.5 mg/dl",
                        "criterion": "total bilirubin",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2.5,
                                "unit": "mg/dl"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Total bilirubin ≤ 2.5 mg/dl",
                        "criterion": "total bilirubin",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2.5,
                                "unit": "mg/dl"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Healthy volunteers allowed",
                "criterions": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "1. Informed consent obtained and signed.",
                "criterions": [
                    {
                        "exact_snippets": "Informed consent obtained and signed",
                        "criterion": "informed consent",
                        "requirement": {
                            "requirement_type": "obtained",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Informed consent obtained and signed",
                        "criterion": "informed consent",
                        "requirement": {
                            "requirement_type": "signed",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Informed consent obtained and signed",
                        "criterion": "informed consent",
                        "requirement": {
                            "requirement_type": "obtained",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Informed consent obtained and signed",
                        "criterion": "informed consent",
                        "requirement": {
                            "requirement_type": "signed",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "3. Participant must be a female and at least 18 years of age at the time of enrollment.",
                "criterions": [
                    {
                        "exact_snippets": "Participant must be a female",
                        "criterion": "sex",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    },
                    {
                        "exact_snippets": "at least 18 years of age at the time of enrollment",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Participant must be a female",
                        "criterion": "sex",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    },
                    {
                        "exact_snippets": "at least 18 years of age at the time of enrollment",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Must be FEMALE",
                "criterions": [
                    {
                        "exact_snippets": "Must be FEMALE",
                        "criterion": "sex",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Must be FEMALE",
                        "criterion": "sex",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "14. Adequate laboratory values within 60 days of enrollment to study defined as follows:",
                "criterions": [
                    {
                        "exact_snippets": "Adequate laboratory values within 60 days of enrollment",
                        "criterion": "laboratory values",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Adequate laboratory values within 60 days of enrollment",
                        "criterion": "laboratory values",
                        "requirement": {
                            "requirement_type": "time window",
                            "expected_value": {
                                "operator": "<=",
                                "value": 60,
                                "unit": "days"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Adequate laboratory values within 60 days of enrollment",
                        "criterion": "laboratory values",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Adequate laboratory values within 60 days of enrollment",
                        "criterion": "laboratory values",
                        "requirement": {
                            "requirement_type": "time window",
                            "expected_value": {
                                "operator": "<=",
                                "value": 60,
                                "unit": "days"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "7. Participant has agreed to provide a core biopsy of the primary site, a secondary metastatic site, or to undergo a paracentesis or thoracentesis for fluid collection.",
                "criterions": [
                    {
                        "exact_snippets": "Participant has agreed to provide a core biopsy of the primary site",
                        "criterion": "core biopsy of the primary site",
                        "requirement": {
                            "requirement_type": "agreement to provide",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Participant has agreed to provide a core biopsy of ... a secondary metastatic site",
                        "criterion": "core biopsy of a secondary metastatic site",
                        "requirement": {
                            "requirement_type": "agreement to provide",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Participant has agreed ... to undergo a paracentesis ... for fluid collection",
                        "criterion": "paracentesis for fluid collection",
                        "requirement": {
                            "requirement_type": "agreement to undergo",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Participant has agreed ... to undergo a ... thoracentesis for fluid collection",
                        "criterion": "thoracentesis for fluid collection",
                        "requirement": {
                            "requirement_type": "agreement to undergo",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Participant has agreed to provide a core biopsy of the primary site",
                        "criterion": "core biopsy of the primary site",
                        "requirement": {
                            "requirement_type": "agreement to provide",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Participant has agreed to provide a core biopsy of ... a secondary metastatic site",
                        "criterion": "core biopsy of a secondary metastatic site",
                        "requirement": {
                            "requirement_type": "agreement to provide",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Participant has agreed ... to undergo a paracentesis ... for fluid collection",
                        "criterion": "paracentesis for fluid collection",
                        "requirement": {
                            "requirement_type": "agreement to undergo",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Participant has agreed ... to undergo a ... thoracentesis for fluid collection",
                        "criterion": "thoracentesis for fluid collection",
                        "requirement": {
                            "requirement_type": "agreement to undergo",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "6. Participants must have an evaluable disease - defined as one of the following:",
                "criterions": [
                    {
                        "exact_snippets": "Participants must have an evaluable disease",
                        "criterion": "evaluable disease",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Participants must have an evaluable disease",
                        "criterion": "evaluable disease",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "8. An adequate fresh sample can be provided and submitted for ChemoID testing.",
                "criterions": [
                    {
                        "exact_snippets": "An adequate fresh sample can be provided and submitted for ChemoID testing.",
                        "criterion": "fresh sample",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "An adequate fresh sample can be provided and submitted for ChemoID testing.",
                        "criterion": "fresh sample",
                        "requirement": {
                            "requirement_type": "freshness",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "An adequate fresh sample can be provided and submitted for ChemoID testing.",
                        "criterion": "fresh sample",
                        "requirement": {
                            "requirement_type": "availability for ChemoID testing",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "An adequate fresh sample can be provided and submitted for ChemoID testing.",
                        "criterion": "fresh sample",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "An adequate fresh sample can be provided and submitted for ChemoID testing.",
                        "criterion": "fresh sample",
                        "requirement": {
                            "requirement_type": "freshness",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "An adequate fresh sample can be provided and submitted for ChemoID testing.",
                        "criterion": "fresh sample",
                        "requirement": {
                            "requirement_type": "availability for ChemoID testing",
                            "expected_value": true
                        }
                    }
                ]
            }
        }
    ],
    "exclusion_lines": [
        {
            "identified_line": {
                "line": "9. Enrollment in another clinical study that precludes allowing the oncologist to select chemotherapy regimens.",
                "criterions": [
                    {
                        "exact_snippets": "Enrollment in another clinical study that precludes allowing the oncologist to select chemotherapy regimens.",
                        "criterion": "enrollment in another clinical study",
                        "requirement": {
                            "requirement_type": "effect on chemotherapy regimen selection",
                            "expected_value": "precludes oncologist from selecting chemotherapy regimens"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Enrollment in another clinical study that precludes allowing the oncologist to select chemotherapy regimens.",
                        "criterion": "enrollment in another clinical study",
                        "requirement": {
                            "requirement_type": "effect on chemotherapy regimen selection",
                            "expected_value": "precludes oncologist from selecting chemotherapy regimens"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "4. Participant is pregnant or lactating.",
                "criterions": [
                    {
                        "exact_snippets": "Participant is pregnant",
                        "criterion": "pregnancy status",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "lactating",
                        "criterion": "lactation status",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Participant is pregnant",
                        "criterion": "pregnancy status",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "lactating",
                        "criterion": "lactation status",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "2. Participant has ovarian stromal, germ cell tumors or pure sarcomas.",
                "criterions": [
                    {
                        "exact_snippets": "Participant has ovarian stromal, germ cell tumors or pure sarcomas.",
                        "criterion": "ovarian stromal tumor",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Participant has ovarian stromal, germ cell tumors or pure sarcomas.",
                        "criterion": "germ cell tumor",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Participant has ovarian stromal, germ cell tumors or pure sarcomas.",
                        "criterion": "pure sarcoma",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Participant has ovarian stromal, germ cell tumors or pure sarcomas.",
                        "criterion": "ovarian stromal tumor",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Participant has ovarian stromal, germ cell tumors or pure sarcomas.",
                        "criterion": "germ cell tumor",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Participant has ovarian stromal, germ cell tumors or pure sarcomas.",
                        "criterion": "pure sarcoma",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "12. CA-125 only disease without RECIST 1.1 measurable or otherwise evaluable disease.",
                "criterions": [
                    {
                        "exact_snippets": "CA-125 only disease",
                        "criterion": "CA-125 only disease",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "without RECIST 1.1 measurable or otherwise evaluable disease",
                        "criterion": "RECIST 1.1 measurable or otherwise evaluable disease",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "CA-125 only disease",
                        "criterion": "CA-125 only disease",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "without RECIST 1.1 measurable or otherwise evaluable disease",
                        "criterion": "RECIST 1.1 measurable or otherwise evaluable disease",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "10. Previously participated in this study.",
                "criterions": [
                    {
                        "exact_snippets": "Previously participated in this study.",
                        "criterion": "prior participation in this study",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "not_criteria": {
                    "exact_snippets": "Previously participated in this study.",
                    "criterion": "prior participation in this study",
                    "requirement": {
                        "requirement_type": "history",
                        "expected_value": true
                    }
                }
            }
        },
        {
            "identified_line": {
                "line": "7. Estimated life expectancy of <6 months, as estimated by the investigator in consultation with participating oncologists.",
                "criterions": [
                    {
                        "exact_snippets": "Estimated life expectancy of <6 months",
                        "criterion": "life expectancy",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Estimated life expectancy of <6 months",
                        "criterion": "life expectancy",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "8. Participants with symptomatic cardiac conditions (i.e. NYHA class III/IV or uncompensated angina).",
                "criterions": [
                    {
                        "exact_snippets": "symptomatic cardiac conditions (i.e. NYHA class III/IV or uncompensated angina)",
                        "criterion": "cardiac conditions",
                        "requirement": {
                            "requirement_type": "symptom presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "symptomatic cardiac conditions (i.e. NYHA class III/IV or uncompensated angina)",
                        "criterion": "cardiac conditions",
                        "requirement": {
                            "requirement_type": "NYHA class",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "N/A"
                            }
                        }
                    },
                    {
                        "exact_snippets": "symptomatic cardiac conditions (i.e. NYHA class III/IV or uncompensated angina)",
                        "criterion": "cardiac conditions",
                        "requirement": {
                            "requirement_type": "angina status",
                            "expected_value": "uncompensated"
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "symptomatic cardiac conditions (i.e. NYHA class III/IV or uncompensated angina)",
                                "criterion": "cardiac conditions",
                                "requirement": {
                                    "requirement_type": "symptom presence",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "symptomatic cardiac conditions (i.e. NYHA class III/IV or uncompensated angina)",
                                "criterion": "cardiac conditions",
                                "requirement": {
                                    "requirement_type": "NYHA class",
                                    "expected_value": {
                                        "operator": ">=",
                                        "value": 3,
                                        "unit": "N/A"
                                    }
                                }
                            }
                        ]
                    },
                    {
                        "exact_snippets": "symptomatic cardiac conditions (i.e. NYHA class III/IV or uncompensated angina)",
                        "criterion": "cardiac conditions",
                        "requirement": {
                            "requirement_type": "angina status",
                            "expected_value": "uncompensated"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "5. Participants of childbearing potential not employing adequate contraception.",
                "criterions": [
                    {
                        "exact_snippets": "Participants of childbearing potential",
                        "criterion": "childbearing potential",
                        "requirement": {
                            "requirement_type": "status",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "not employing adequate contraception",
                        "criterion": "contraception use",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Participants of childbearing potential",
                        "criterion": "childbearing potential",
                        "requirement": {
                            "requirement_type": "status",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "not employing adequate contraception",
                        "criterion": "contraception use",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": false
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "3. Participant has borderline carcinoma (uncertain malignant potential), mutinous or low-grade serous carcinoma.",
                "criterions": [
                    {
                        "exact_snippets": "Participant has borderline carcinoma (uncertain malignant potential)",
                        "criterion": "borderline carcinoma",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "mutinous ... carcinoma",
                        "criterion": "mutinous carcinoma",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "low-grade serous carcinoma",
                        "criterion": "low-grade serous carcinoma",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Participant has borderline carcinoma (uncertain malignant potential)",
                        "criterion": "borderline carcinoma",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "mutinous ... carcinoma",
                        "criterion": "mutinous carcinoma",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "low-grade serous carcinoma",
                        "criterion": "low-grade serous carcinoma",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "11. Any condition that would, in the opinion of the investigator, place the participant at an unacceptable risk, or render the participant unable to meet the requirements of the protocol (including long-term study follow-up).",
                "criterions": [
                    {
                        "exact_snippets": "Any condition that would, in the opinion of the investigator, place the participant at an unacceptable risk",
                        "criterion": "any condition causing unacceptable risk",
                        "requirement": {
                            "requirement_type": "risk (as judged by investigator)",
                            "expected_value": "unacceptable"
                        }
                    },
                    {
                        "exact_snippets": "Any condition that would ... render the participant unable to meet the requirements of the protocol (including long-term study follow-up)",
                        "criterion": "any condition affecting ability to meet protocol requirements",
                        "requirement": {
                            "requirement_type": "ability to meet protocol requirements",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Any condition that would, in the opinion of the investigator, place the participant at an unacceptable risk",
                        "criterion": "any condition causing unacceptable risk",
                        "requirement": {
                            "requirement_type": "risk (as judged by investigator)",
                            "expected_value": "unacceptable"
                        }
                    },
                    {
                        "exact_snippets": "Any condition that would ... render the participant unable to meet the requirements of the protocol (including long-term study follow-up)",
                        "criterion": "any condition affecting ability to meet protocol requirements",
                        "requirement": {
                            "requirement_type": "ability to meet protocol requirements",
                            "expected_value": false
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "1. Use of Avastin planned to treat participant.",
                "criterions": [
                    {
                        "exact_snippets": "Use of Avastin planned to treat participant.",
                        "criterion": "planned use of Avastin",
                        "requirement": {
                            "requirement_type": "planned use",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "not_criteria": {
                    "exact_snippets": "Use of Avastin planned to treat participant.",
                    "criterion": "planned use of Avastin",
                    "requirement": {
                        "requirement_type": "planned use",
                        "expected_value": true
                    }
                }
            }
        },
        {
            "identified_line": {
                "line": "13. Patients with third space fluid (for example pleural effusions) as only site of disease.",
                "criterions": [
                    {
                        "exact_snippets": "third space fluid (for example pleural effusions) as only site of disease",
                        "criterion": "third space fluid as only site of disease",
                        "requirement": {
                            "requirement_type": "disease site",
                            "expected_value": "third space fluid only"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "third space fluid (for example pleural effusions) as only site of disease",
                        "criterion": "third space fluid as only site of disease",
                        "requirement": {
                            "requirement_type": "disease site",
                            "expected_value": "third space fluid only"
                        }
                    }
                ]
            }
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "identified_line": {
                "line": "13. Participant must have an ECOG Performance Status Score of ≤ 2, KPS≥70, or 0-2 GOG status.",
                "criterions": [
                    {
                        "exact_snippets": "ECOG Performance Status Score of ≤ 2",
                        "criterion": "ECOG Performance Status Score",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "N/A"
                            }
                        }
                    },
                    {
                        "exact_snippets": "KPS≥70",
                        "criterion": "Karnofsky Performance Status (KPS)",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 70,
                                "unit": "N/A"
                            }
                        }
                    },
                    {
                        "exact_snippets": "0-2 GOG status",
                        "criterion": "GOG Performance Status",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "ECOG Performance Status Score of \u00102",
                        "criterion": "ECOG Performance Status Score",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "N/A"
                            }
                        }
                    },
                    {
                        "exact_snippets": "KPS\u001370",
                        "criterion": "Karnofsky Performance Status (KPS)",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 70,
                                "unit": "N/A"
                            }
                        }
                    },
                    {
                        "exact_snippets": "0-2 GOG status",
                        "criterion": "GOG Performance Status",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "5. Participant has been diagnosed with recurrent platinum resistant epithelial ovarian, peritoneal, or fallopian tube carcinoma.",
                "criterions": [
                    {
                        "exact_snippets": "diagnosed with recurrent platinum resistant epithelial ovarian, peritoneal, or fallopian tube carcinoma",
                        "criterion": "carcinoma type",
                        "requirement": {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "diagnosed with recurrent platinum resistant epithelial ovarian, peritoneal, or fallopian tube carcinoma",
                        "criterion": "carcinoma type",
                        "requirement": {
                            "requirement_type": "recurrence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "diagnosed with recurrent platinum resistant epithelial ovarian, peritoneal, or fallopian tube carcinoma",
                        "criterion": "carcinoma type",
                        "requirement": {
                            "requirement_type": "platinum resistance",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "diagnosed with recurrent platinum resistant epithelial ovarian, peritoneal, or fallopian tube carcinoma",
                        "criterion": "carcinoma type",
                        "requirement": {
                            "requirement_type": "histology",
                            "expected_value": [
                                "epithelial ovarian carcinoma",
                                "peritoneal carcinoma",
                                "fallopian tube carcinoma"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "10. Participant has received ≤ 5 prior regimens including at least one platinum-based regimen for their ovarian, peritoneal, or fallopian tube carcinoma.",
                "criterions": [
                    {
                        "exact_snippets": "Participant has received ≤ 5 prior regimens",
                        "criterion": "number of prior regimens",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 5,
                                "unit": "regimens"
                            }
                        }
                    },
                    {
                        "exact_snippets": "including at least one platinum-based regimen",
                        "criterion": "prior platinum-based regimen",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "for their ovarian, peritoneal, or fallopian tube carcinoma",
                        "criterion": "cancer type",
                        "requirement": {
                            "requirement_type": "type",
                            "expected_value": [
                                "ovarian carcinoma",
                                "peritoneal carcinoma",
                                "fallopian tube carcinoma"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "2. Hgb ≥ 10 mg/dl",
                "criterions": [
                    {
                        "exact_snippets": "Hgb ≥ 10 mg/dl",
                        "criterion": "hemoglobin (Hgb) level",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 10,
                                "unit": "mg/dl"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Hgb \u001e 10 mg/dl",
                        "criterion": "hemoglobin (Hgb) level",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 10,
                                "unit": "mg/dl"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "4. Platelet count ≥ 100,000/μL",
                "criterions": [
                    {
                        "exact_snippets": "Platelet count ≥ 100,000/μL",
                        "criterion": "platelet count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 100000,
                                "unit": "/μL"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Platelet count \u001e 100,000/\u00181\u001eL",
                        "criterion": "platelet count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 100000,
                                "unit": "/\u00181\u001eL"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "3. Hct ≥ 28%",
                "criterions": [
                    {
                        "exact_snippets": "Hct ≥ 28%",
                        "criterion": "hematocrit (Hct)",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 28,
                                "unit": "%"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Hct  28%",
                        "criterion": "hematocrit (Hct)",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 28,
                                "unit": "%"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "7. AST/SGOT ≤ 3 times ULN. If intrahepatic liver metastases are present, AST and ALT must be ≤ 5 times institutional ULN.",
                "criterions": [
                    {
                        "exact_snippets": "AST/SGOT ≤ 3 times ULN",
                        "criterion": "AST/SGOT",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "times ULN"
                            }
                        }
                    },
                    {
                        "exact_snippets": "If intrahepatic liver metastases are present, AST and ALT must be ≤ 5 times institutional ULN",
                        "criterion": "AST and ALT (with intrahepatic liver metastases)",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 5,
                                "unit": "times institutional ULN"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "condition": {
                    "exact_snippets": "If intrahepatic liver metastases are present, AST and ALT must be \u001e 5 times institutional ULN",
                    "criterion": "AST and ALT (with intrahepatic liver metastases)",
                    "requirement": {
                        "requirement_type": "quantity",
                        "expected_value": {
                            "operator": "<=",
                            "value": 5,
                            "unit": "times institutional ULN"
                        }
                    }
                },
                "then_criteria": null,
                "else_criteria": {
                    "exact_snippets": "AST/SGOT \u001e 3 times ULN",
                    "criterion": "AST/SGOT",
                    "requirement": {
                        "requirement_type": "quantity",
                        "expected_value": {
                            "operator": "<=",
                            "value": 3,
                            "unit": "times ULN"
                        }
                    }
                }
            }
        },
        {
            "identified_line": {
                "line": "5. Serum creatinine ≤ 2.0 mg/dl",
                "criterions": [
                    {
                        "exact_snippets": "Serum creatinine ≤ 2.0 mg/dl",
                        "criterion": "serum creatinine",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2.0,
                                "unit": "mg/dl"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Serum creatinine \u0013 2.0 mg/dl",
                        "criterion": "serum creatinine",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2.0,
                                "unit": "mg/dl"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "1) RECIST 1.1 measurable disease (defined as one or more solid and/or cystic tumors on cross-sectional imaging that measures 1 cm or greater in long axis and/or lymph nodes measuring 1.5 cm or greater in short axis) 2) Evaluable disease (defined as solid and/or cystic tumors on radiographic imaging or physical exam that do not meet RECIST 1.1 definitions for target lesions) with elevated CA125 (GCIG recurrence and response criteria) by more than 2 times the upper limits of normal, confirmed in two successive samples, drawn at least one week apart).",
                "criterions": [
                    {
                        "exact_snippets": "RECIST 1.1 measurable disease (defined as one or more solid and/or cystic tumors on cross-sectional imaging that measures 1 cm or greater in long axis and/or lymph nodes measuring 1.5 cm or greater in short axis)",
                        "criterion": "RECIST 1.1 measurable disease",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "solid and/or cystic tumors on cross-sectional imaging that measures 1 cm or greater in long axis",
                        "criterion": "solid and/or cystic tumor size (long axis)",
                        "requirement": {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "cm"
                            }
                        }
                    },
                    {
                        "exact_snippets": "solid and/or cystic tumors on cross-sectional imaging that measures 1 cm or greater in long axis",
                        "criterion": "solid and/or cystic tumor size (long axis)",
                        "requirement": {
                            "requirement_type": "imaging_modality",
                            "expected_value": "cross-sectional imaging"
                        }
                    },
                    {
                        "exact_snippets": "lymph nodes measuring 1.5 cm or greater in short axis",
                        "criterion": "lymph node size (short axis)",
                        "requirement": {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1.5,
                                "unit": "cm"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Evaluable disease (defined as solid and/or cystic tumors on radiographic imaging or physical exam that do not meet RECIST 1.1 definitions for target lesions)",
                        "criterion": "evaluable disease (non-RECIST 1.1)",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "solid and/or cystic tumors on radiographic imaging or physical exam that do not meet RECIST 1.1 definitions for target lesions",
                        "criterion": "solid and/or cystic tumor (non-RECIST 1.1)",
                        "requirement": {
                            "requirement_type": "detection_method",
                            "expected_value": [
                                "radiographic imaging",
                                "physical exam"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "solid and/or cystic tumors on radiographic imaging or physical exam that do not meet RECIST 1.1 definitions for target lesions",
                        "criterion": "solid and/or cystic tumor (non-RECIST 1.1)",
                        "requirement": {
                            "requirement_type": "RECIST 1.1 target lesion status",
                            "expected_value": "does not meet"
                        }
                    },
                    {
                        "exact_snippets": "elevated CA125 (GCIG recurrence and response criteria) by more than 2 times the upper limits of normal, confirmed in two successive samples, drawn at least one week apart",
                        "criterion": "CA125 level",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 2,
                                "unit": "x upper limit of normal"
                            }
                        }
                    },
                    {
                        "exact_snippets": "elevated CA125 (GCIG recurrence and response criteria) by more than 2 times the upper limits of normal, confirmed in two successive samples, drawn at least one week apart",
                        "criterion": "CA125 level",
                        "requirement": {
                            "requirement_type": "confirmation",
                            "expected_value": "confirmed in two successive samples, drawn at least one week apart"
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "9. Participant has disease of one of the following histologic epithelial cell types: high-grade serous adenocarcinoma, endometrioid adenocarcinoma, undifferentiated carcinoma, transitional cell carcinoma, clear cell carcinoma, or adenocarcinoma, not otherwise specified (N.O.S.). Cytologic confirmation of diagnosis is acceptable for participants treated with neoadjuvant therapy who have not had a surgical procedure for a histologic confirmation. Patients with low-grade serous or mucinous adenocarcinoma are not eligible, nor are patients with pure ovarian sarcomas.",
                "criterions": [
                    {
                        "exact_snippets": "Participant has disease of one of the following histologic epithelial cell types: high-grade serous adenocarcinoma, endometrioid adenocarcinoma, undifferentiated carcinoma, transitional cell carcinoma, clear cell carcinoma, or adenocarcinoma, not otherwise specified (N.O.S.)",
                        "criterion": "histologic epithelial cell type",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": [
                                "high-grade serous adenocarcinoma",
                                "endometrioid adenocarcinoma",
                                "undifferentiated carcinoma",
                                "transitional cell carcinoma",
                                "clear cell carcinoma",
                                "adenocarcinoma, not otherwise specified (N.O.S.)"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "Cytologic confirmation of diagnosis is acceptable for participants treated with neoadjuvant therapy who have not had a surgical procedure for a histologic confirmation",
                        "criterion": "diagnosis confirmation method",
                        "requirement": {
                            "requirement_type": "method",
                            "expected_value": [
                                "cytologic confirmation (if treated with neoadjuvant therapy and no surgical histologic confirmation)"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "Patients with low-grade serous or mucinous adenocarcinoma are not eligible",
                        "criterion": "histologic epithelial cell type",
                        "requirement": {
                            "requirement_type": "exclusion",
                            "expected_value": [
                                "low-grade serous adenocarcinoma",
                                "mucinous adenocarcinoma"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "nor are patients with pure ovarian sarcomas",
                        "criterion": "histologic cell type",
                        "requirement": {
                            "requirement_type": "exclusion",
                            "expected_value": [
                                "pure ovarian sarcomas"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        }
    ],
    "failed_exclusion": [
        {
            "identified_line": {
                "line": "6. Participants who are at risk of failure of compliance to the visit schedules and procedures including those with psychiatric disease that would substantially impact compliance or consent.",
                "criterions": [
                    {
                        "exact_snippets": "Participants who are at risk of failure of compliance to the visit schedules and procedures",
                        "criterion": "risk of non-compliance to visit schedules and procedures",
                        "requirement": {
                            "requirement_type": "risk",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "psychiatric disease that would substantially impact compliance or consent",
                        "criterion": "psychiatric disease impacting compliance or consent",
                        "requirement": {
                            "requirement_type": "impact on compliance or consent",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Participants who are at risk of failure of compliance to the visit schedules and procedures",
                        "criterion": "risk of non-compliance to visit schedules and procedures",
                        "requirement": {
                            "requirement_type": "risk",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "psychiatric disease that would substantially impact compliance or consent",
                        "criterion": "psychiatric disease impacting compliance or consent",
                        "requirement": {
                            "requirement_type": "impact on compliance or consent",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "14. Participant may not use any complementary or alternative medicines including natural herbal products or folk remedies as they may interfere with the effectiveness of the study treatments.",
                "criterions": [
                    {
                        "exact_snippets": "Participant may not use any complementary or alternative medicines including natural herbal products or folk remedies",
                        "criterion": "use of complementary or alternative medicines",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "Participant may not use any ... natural herbal products",
                        "criterion": "use of natural herbal products",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "Participant may not use any ... folk remedies",
                        "criterion": "use of folk remedies",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Participant may not use any complementary or alternative medicines including natural herbal products or folk remedies",
                        "criterion": "use of complementary or alternative medicines",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Participant may not use any ... natural herbal products",
                        "criterion": "use of natural herbal products",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Participant may not use any ... folk remedies",
                        "criterion": "use of folk remedies",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        }
    ],
    "failed_miscellaneous": []
}